Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions
As rates of pancreatic and breast cancer increase among the population, Cannabis Bioscience International Holdings (OTC:CBIH) is addressing the situation with new treatment methodologies. The Houston-based company submitted its inaugural pair of patents, targeting those with breast and pancreatic cancers for legal review and subsequent registration.
Why It Matters
These two cancers affect millions globally. Breast cancer impacts roughly one in eight women in the U.S. and pancreatic cancer is notorious for its late-stage diagnosis and grim prognosis, with a five-year survival rate below 10%.
“Given the stark statistics associated with these cancers, our team recognizes the critical need for aggressive yet targeted interventions,” said Jennifer Salguero, PhD in …